Allogeneic and autologous bone marrow transplantation in AML in first remission, the Spanish experience.

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 2, 1996, Pages 53-58

  Ortega, J J ^a,b   Olive T ^a   Diaz De Heredia C ^a   Coll, M T ^a   Bastida, P ^a   Massuet, Ll ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MAFOSFAMIDE; METHOTREXATE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CHILD; CLINICAL PROTOCOL; CONFERENCE PAPER; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; SPAIN; SURVIVAL; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; SPAIN; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0029810202     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Ravindranath Y, Steuber CP, Krishner J et al. High dose cytarabine for intensification of early therapy of childhood of acute myeloid leukemia: a Pediatric Oncology Group Study. JClin Oncol 1991; 9:572-580.
2. Wells RJ, Woods WG, Lampkin BC et al. Impact of high -dose Cytarabine and Asparaginase intensification in Childhood Acute Myeloid Leukemia:a report from the Children's Cancer Group.JClin Oncology 1993; 11:538-545.
3. Nesbitt M, Bucley JD, Feig SA et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by Marrow Transplantation or multiagent chemotherapy: a report from the Children's cancer Group. JClin Oncol 1994; 12:127-135.
4. Amadori S, Testi AM, Arico M et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukaemia. JClin Oncol 1993; 11: 1046-1054.
5. Creutzig U, Ritter J, Schellong G. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BMF-78. Blood 1990; 75: 1932-1940.
6. Creutzig U, Ritter J, Zimmermann M et al. Does cranial irradiation reduce the risk for bone marrow relap se in acute myelogenous leukaemia? Unexepected results of the childhood acute myelogenous leukaemia study BFM-87. JClin Oncol 1993; 11: 279-286.
7. Wolff SN, Marion J, Stein RS et al. High-dose cytosine-arabinoside and daunorubicin as consolidation therapy for acute non lymphocitic leukemia in first remission: a pilot study. Blood 1985;65: 1407-1411.
8. Trico G, Boogaerts MA, Vlientick R et al. The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia. Br JHaematol 1987; 66: 17-44.
9. Reiffers J, Gaspard MH, Maraninchi D et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br JHaematol 1989; 72: 57-63.
10. Dahl GV, Kalwinsky DK, Mirro J et al. Allogeneic Bone Marrow Transplantation in a Program of Intensive sequential chemotherapy for children and young adults with Acute Nonlymphocitic Leukaemia in first remission. J Clin Oncol 1990; 8: 295-303.
11. Linker C, Ries C, Damon L et al. Autologous Bone marrow transplantation for acute myeloid leukaemia using busulfan plus etoposide as a preparative regimen. Blood 1993; 81: 311-318.
12. Casilleth PA, Anderson J, Lazarus HM et al. Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314-319.
13. Lie SO. Treatment of acute myeloid leukaemia in children. Bailliere 's Clin Paediat 1995; 3: 757-778.
14. Michel G, Leverger G, Leblanc T et al. Allogeneic bone marrow transplantation vs agressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology. Bone Marrow Transplant 1996; 17: 191-196.
15. Dirmdorf P, Bunin N. Bone Marrow Transplantation for children with Acute Myelogenous Leukemia. J Pediatr Hematol/Oncol 1995; 17: 211-224.
16. Zittoun RA, Mandelli F, Willanze R et al. Autologous or allogeneic chemotherapy in adults with acute myeloid leukemia. NEng JMed 1995; 332: 217-223.
17. Tiedemann K, Waters K, Tauro G et al. Results of intensive therapy in childhood acute myeloid leukemia incorporating high-dose melphalan and autologous bone marrow transplantation in first remission. Blood 1993; 82: 3730-3738.
18. Zintl F, Hermann J, Fuchs D et al. Comparison of allogeneic and autologous bone marrow transplantation for treatment of acute myeloblastic leukemia in childhood in first complete remission. Blood 1994; 84 (suppl.1): 725a.